Artimis
Phase 1- Indications
- Post-meniscectomy pain, Knee osteoarthritis
Company intelligence / Profile preview
ATRO Medical is developing the Artimis® meniscus prosthesis, a synthetic, anatomically shaped implant designed to replace damaged or absent lateral menisci in the knee. The company has initiated first-in-human clinical trials in Europe and received FDA Breakthrough Device Designation for its technology. Early results focus on safety and feasibility, with ongoing studies assessing pain reduction and functional improvement over two years of follow-up[2][8][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ATRO Medical.